Hematolojik kanser tanısıyla yoğun bakım ünitesinde takip edilen hastaların klinik özelliklerinin ve sonuçlarının değerlendirilmesi: tek merkez deneyimi
Author:
AKBUDAK İsmail Hakkı
Publisher
Pamukkale Tip Dergisi
Reference19 articles.
1. Vijenthira A, Chiu N, Jacobson D, et al. Predictors of intensive care unit admission in patients with hematologic malignancy. Sci Rep 2020;10:21145. https://doi.org/10.1038/s41598-020-78114-7
2. Cornish M, Butler MB, Green RS. Predictors of poor outcomes in critically Ill adults with hematologic malignancy. Can Respir J 2016;2016:9431385. https://doi.org/10.1155/2016/9431385
3. Hill QA, Kelly RJ, Patalappa C, et al. Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study. Leuk Lymphoma. 2012;53:282-288. https://doi.org/10.3109/10428194.2011.614705
4. Bird GT, Farquhar Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 2012;108:452-459. https://doi.org/10.1093/bja/aer449
5. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315:801–10. https://doi.org/10.1001/jama.2016.0287